Is it too early to dismiss corticosteroids in CDK4/6 inhibitor-induced liver injury?

JHEP Reports · Published 2026-07-01 · DOI 10.1016/j.jhepr.2026.101973

Free full text

Authors (6)

Lucy Meunier, Eleonora De Martin, Bénédicte Delire, Lucia Parlati, Dominique Larrey, Yves Horsmans

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Meunier, L., Martin, E., Delire, B., et al. (2026). Is it too early to dismiss corticosteroids in CDK4/6 inhibitor-induced liver injury?. JHEP Reports. https://doi.org/10.1016/j.jhepr.2026.101973

Related articles

• Second-line practices in the era of immunotherapy in HCC: The CHIEF cohort · JHEP Reports · 2026 · Same journal
• Interleukin-8–driven monocyte activation in primary sclerosing cholangitis: Insights from single-cell analysis and humanized immune system mice · JHEP Reports · 2026 · Same journal
• A hepatocyte-derived GPNMB–RYK signaling axis in MASH progression · JHEP Reports · 2026 · Same journal
• Development and psychometric evaluation of the Liver Disease Stigma Scale (LDSS) · JHEP Reports · 2026 · Same journal
• Global Trends in National Alcohol Control Policies Between 2010–2019 · JHEP Reports · 2026 · Same journal
• Peripartum ALT Flares Predict Earlier Postpartum HBeAg Clearance in Highly Viremic HBV-Infected Women: A Long-term Follow-up Study · JHEP Reports · 2026 · Same journal
• The Use of FGF21 Analogues in MASH and MASH Cirrhosis – Metabolic Master Regulators or Liver-Specific Mechanisms? ☆ · JHEP Reports · 2026 · Same journal
• Hepatic flares, their immune signatures, and ALT variability after nucleos(t)ide analogue cessation in HBeAg-negative hepatitis B · JHEP Reports · 2026 · Same journal
• Changes in alcohol use following a diagnosis of alcohol-related liver disease: a clinical cohort study · JHEP Reports · 2026 · Same journal
• Corticosteroids in severe alcohol-related hepatitis: a multicenter randomized clinical trial · JHEP Reports · 2026 · Same journal